FDA perspective on assessing the clinical benefit of cardiac resynchronization and implantable cardioverter-defibrillator devices

被引：0
|
作者：
Selzman, Kimberly A. [1 ]
机构：
[1] US FDA, Div Cardiovasc Devices, Off Device Evaluat, Ctr Devices & Radiol Hlth, White Oak Campus,Bldg 66,10903 New Hampshire Ave, Silver Spring, MD 20903 USA
来源：
JOURNAL OF ELECTROCARDIOLOGY | 2018年 / 51卷 / 06期
关键词：
HEART-FAILURE; THERAPY;
D O I：
10.1016/j.jelectrocard.2018.08.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S22 / S24
页数：3
相关论文
共 50 条
  • [1] Indications for Pacemakers, Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Devices
    Samii, Soraya M.
    MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (04) : 795 - +
  • [2] Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator
    Daubert, J. Claude
    Leclercq, Christophe
    Mabo, Philippe
    EUROPACE, 2009, 11 : 87 - 92
  • [3] Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy
    Kühlkamp, V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 790 - 797
  • [4] Incidence of Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Heart Failure Treated With Combined Cardiac Resynchronization Plus Implantable Cardioverter-Defibrillator Therapy Versus Implantable Cardioverter-Defibrillator Therapy
    Desai, Harit
    Aronow, Wilbert S.
    Ahn, Chul
    Tsai, Fausan S.
    Lai, Hoang M.
    Gandhi, Kaushang
    Amin, Harshad
    Frishman, William H.
    Kalapatapu, Kumar
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 37 - 40
  • [5] The implantable cardioverter-defibrillator - Patient perspective
    Reiffel, JA
    Dizon, J
    CIRCULATION, 2002, 105 (09) : 1022 - 1024
  • [6] Assessing the benefit of a replacement implantable cardioverter-defibrillator device for primary prevention of sudden cardiac death
    Auricchio, A.
    Curtis, A. B.
    Mittal, S.
    Pickett, R. A.
    Jacobsen, L.
    Lande, J. D.
    Wilkoff, B. L.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [7] Predicting benefit for implantable cardioverter-defibrillator use
    Soliman, Elsayed Z.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03): : 286 - 287
  • [8] Underutilization of β-Blockers in Patients Undergoing Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Procedures
    Hauptman, Paul J.
    Swindle, Jason P.
    Masoudi, Frederick A.
    Burroughs, Thomas E.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (02): : 204 - 211
  • [9] National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator
    Lindvall, Charlotta
    Chatterjee, Neal A.
    Chang, Yuchiao
    Chernack, Betty
    Jackson, Vicki A.
    Singh, Jagmeet P.
    Metlay, Joshua P.
    CIRCULATION, 2016, 133 (03) : 273 - 281
  • [10] Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompaction
    Kobza, Richard
    Steffel, Jan
    Erne, Paul
    Schoenenberger, Andreas W.
    Huerlimann, David
    Luescher, Thomas F.
    Jenni, Rolf
    Duru, Firat
    HEART RHYTHM, 2010, 7 (11) : 1545 - 1549
12345